January 20, 2022 – Washington, D.C. (link to article) – A new national poll of registered voters in the United States shows that the majority of respondents would utilize pharmaceutical intervention to target aspects of aging if the drugs or therapies were safe, effective, affordable, and available to all. This trend was true for members of both political parties, with 74% of Democrats and 62% of Republicans reporting that they would utilize these therapies.
The poll, which was conducted by Public Policy Polling on behalf of The Alliance for Longevity Initiatives (A4LI), also found that Democrats (79%) and Republicans (59%) support research into cellular aging. This process has been identified by researchers to be the root cause of many chronic and often-fatal diseases, including cancer, Alzheimer’s disease and dementia, heart disease, stroke, diabetes, and others. Aging and age-related diseases cause about 70% of daily deaths.
Respondents identified a number of priority areas which they feel the government should focus on, including improving the health of citizens, combating climate change, combating poverty, and reducing the national debt. But an improvement in a person’s expected healthspan – the length of a person’s life during which they are in generally good health – would not only enhance health outcomes.
Healthier, longer lives could raise the age of retirement and reduce medical debt – the leading cause of bankruptcy – in addition to having positive implications for social safety net programs such as Medicare and Medicaid and providing a boost to the overall economy. A4LI works to educate policymakers on the widespread benefits of this innovative field and address current barriers in longevity science.
“We’re excited to see that so many Americans share our view of the importance of promoting better, longer lives for our citizens,” said A4LI Founder & President Dylan Livingston. “Longevity science is advancing rapidly, and it’s vital that policymakers ensure that the U.S. is ready to benefit from the coming wave of innovation.”
The full results from the poll are available online.
Media Inquiries
For more information or for media requests, please contact Dylan Livingston, Founder & President of A4LI, at [email protected].
About The Alliance for Longevity Initiatives
The Alliance for Longevity Initiatives is the first and only 501(c)(4) nonprofit organization founded with the goal of creating social and political action around the issues of combating age-related chronic conditions and increasing our number of healthy, disease-free years. A4LI works with healthcare leaders and experts in the geroscience and regenerative medicine fields to ensure the initiatives we pursue are the right steps to accomplish A4LI’s mission. Ultimately, we would like to see governments around the world prioritize keeping their citizens in excellent health for much longer.
